Margaret Kasner, MD
Enriched profileProfessor, Medical Oncology · Thomas Jefferson University
Margaret Kasner is Professor, Medical Oncology at Thomas Jefferson University. OpenAlex indexes 144 publications with 2,542 citations (h-index 19); ClinicalTrials.gov lists 8 registered studies with this person as an investigator.
Data verified 23 Oct 2026
Overview
Updated 27 Oct 2026
Margaret T. Kasner, M.D., is Professor, Medical Oncology at Thomas Jefferson University (Sidney Kimmel Comprehensive Cancer Center). The public record shows 144 publications with 2,542 citations (h-index 19), centered on Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation, Retinoids in leukemia and cellular processes. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 11 companies, 1 NIH-funded awards (2020–2022).
- Most recent indexed publication: 2026 · Cancers
- Top research focus: Acute Myeloid Leukemia Research
- 8 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 27 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 25.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 26 Oct 2026
Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:
- Palbociclib and Dexamethasone in Treating Participants With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- STAT Inhibitor OPB-111077, Decitabine and Venetoclax in Treating Patients With Acute Myeloid Leukemia That Is Refractory, Relapsed or Newly Diagnosed and Ineligible for Intensive Chemotherapy
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Industry payments
Updated 26 Oct 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Geron CorporationProgram year20254 payments
- Daiichi Sankyo Inc.Program year20253 payments
- Janssen Research & Development, LLCProgram year20253 payments
NIH funding
Updated 26 Oct 2026
1 NIH research award on record, funded 2020–2022 per NIH RePORTER. The latest:
Congress activity
Updated 26 Oct 2026
30 congress contributions (2017–2025) across AACR, ASCO, ASH, ASTRO per OpenAlex. The most recent:
- Safety evaluation for less restrictive discharge criteria for patients receiving high dose methotrexate
ASH Annual Meeting
ASH2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 26 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- North American Cancer Center Clinical Research Capacity and Benchmarking in the Postpandemic Era.
JCO oncology practice
Article2024
Most-cited works
by citation count (OpenAlex)- 01Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3 -Mutated AMLArticle1,282 citations2019
- 02
- 03
- 04
- 05
Network
Updated 26 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 26 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/margaret-kasner-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
binaytara.org/projects/conferences/speakers/margaret-kasner
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →binaytara.org ↗ - Other
jefferson.edu/academics/colleges-schools-institutes/skmc/departments/medical-oncology/faculty/kasner.html
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →jefferson.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 26 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →jefferson.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →jefferson.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →jefferson.edu ↗
Editorial & leadership roles
journal and society appointments- Director
Leukemia Group
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu ↗ - Director
Division of Hematologic Malignancies
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu ↗ - Associate Director
Clinical Research, Sidney Kimmel Comprehensive Cancer Center
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu ↗ - Appointed Member
Committee on Educational Affairs, American Society of Hematology ('26)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hematology.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthtree.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
David Whellan, MD
Thomas Jefferson University
Jesse Roman, MD
Thomas Jefferson University
Wenyin Shi, MD
Thomas Jefferson University
Stephen Silberstein, MD
Thomas Jefferson University
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Jorge Cortes, MD
University of Alabama at Birmingham (UAB)
Ayalew Tefferi, MD
Mayo Clinic
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center